...
首页> 外文期刊>American Journal of Physiology >A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo.
【24h】

A1 adenosine receptor knockout mice are protected against acute radiocontrast nephropathy in vivo.

机译:A1腺苷受体敲除小鼠在体内可预防急性放射性对比肾病。

获取原文
获取原文并翻译 | 示例

摘要

The role of renal A1 adenosine receptors (A1AR) in the pathogenesis of radiocontrast nephropathy is controversial. We aimed to further elucidate the role of A1AR in the pathogenesis of radiocontrast nephropathy and determine whether renal proximal tubule A1AR contribute to the radiocontrast nephropathy. To induce radiocontrast nephropathy, A1AR wild-type (WT) or knockout (KO) mice were injected with a nonionic radiocontrast (iohexol, 1.5-3 g iodine/kg). Some A1WT mice were pretreated with 8-cyclopentyl-1,3-dipropylxanthine (DPCPX; a selective A1AR antagonist) before iohexol injection. A1AR contribute to the pathogenesis of radiocontrast nephropathy in vivo as the A1WT mice developed significantly worse acute renal failure, more renal cortex vacuolization, and had lower survival 24 h after iohexol treatment compared with the A1KO mice. DPCPX pretreatment also protected the A1WT mice against radiocontrast-induced acute renal failure. No differences in renal cortical apoptosis or inflammation were observed between A1WT and A1KO mice. To determine whether the proximal tubular A1AR mediate the direct renal cytotoxicity of radiocontrast, we treated proximal tubules in culture with iohexol with or without 2-chloro-N6-cyclopentyladenosine (a selective A1AR agonist) or DPCPX pretreatment. We also subjected cultured proximal tubule cells overexpressing A1AR or lacking A1AR to radiocontrast injury. Iohexol caused a direct dose-dependent reduction in proximal tubule cell viability as well as proliferation. Neither the A1AR agonist nor the antagonist treatment affected proximal tubule viability or proliferation. Moreover, overexpression or lack of A1AR failed to impact the iohexol toxicity on proximal tubule cells. Therefore, we conclude that radiocontrast causes acute renal failure via mechanisms dependent on A1AR; however, renal proximal tubule A1AR do not contribute to the direct tubular toxicity of radiocontrast.
机译:肾A1腺苷受体(A1AR)在放射性对比肾病发病机理中的作用尚有争议。我们旨在进一步阐明A1AR在放射性对比肾病发病机理中的作用,并确定肾近端小管A1AR是否有助于放射性对比肾病。为了诱发放射性对比肾病,给A1AR野生型(WT)或敲除(KO)小鼠注射非离子放射性对比剂(iohexol,1.5-3 g碘/ kg)。在注射碘海醇之前,某些A1WT小鼠用8-环戊基-1,3-二丙基黄嘌呤(DPCPX;选择性A1AR拮抗剂)进行了预处理。与A1KO小鼠相比,A1WT小鼠在碘海醇治疗后24小时出现严重的急性肾衰竭,更多的肾皮质空泡化,并具有较低的存活率,这是因为A1WT小鼠在体内显着恶化了急性肾衰竭。 DPCPX预处理还可以保护A1WT小鼠免于放射性造影剂诱发的急性肾衰竭。在A1WT和A1KO小鼠之间未观察到肾皮质凋亡或炎症的差异。为了确定近端肾小管A1AR是否介导放射性对比剂的直接肾细胞毒性,我们用碘海醇在有或没有2-氯-N6-环戊基腺苷(选择性A1AR激动剂)或DPCPX预处理的情况下处理了近端肾小管。我们还对过表达的A1AR或缺乏A1AR的近端肾小管细胞进行了放射性对比剂损伤。碘海醇引起近端肾小管细胞活力以及增殖的直接剂量依赖性降低。 A1AR激动剂和拮抗剂治疗都不会影响近端小管的生存能力或增殖。此外,A1AR的过表达或缺乏未能影响碘海醇对近端小管细胞的毒性。因此,我们得出结论,放射性造影剂通过依赖于A1AR的机制导致急性肾功能衰竭。但是,肾近端小管A1AR不会对放射性造影剂产生直接的肾小管毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号